JP2024541994A5 - - Google Patents

Info

Publication number
JP2024541994A5
JP2024541994A5 JP2024525414A JP2024525414A JP2024541994A5 JP 2024541994 A5 JP2024541994 A5 JP 2024541994A5 JP 2024525414 A JP2024525414 A JP 2024525414A JP 2024525414 A JP2024525414 A JP 2024525414A JP 2024541994 A5 JP2024541994 A5 JP 2024541994A5
Authority
JP
Japan
Prior art keywords
disease
alkyl
independently
heterocycloalkyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541994A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079326 external-priority patent/WO2023081841A1/en
Publication of JP2024541994A publication Critical patent/JP2024541994A/ja
Publication of JP2024541994A5 publication Critical patent/JP2024541994A5/ja
Pending legal-status Critical Current

Links

JP2024525414A 2021-11-05 2022-11-04 Akt3モジュレーター Pending JP2024541994A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163276115P 2021-11-05 2021-11-05
US63/276,115 2021-11-05
PCT/US2022/079326 WO2023081841A1 (en) 2021-11-05 2022-11-04 Akt3 modulators

Publications (2)

Publication Number Publication Date
JP2024541994A JP2024541994A (ja) 2024-11-13
JP2024541994A5 true JP2024541994A5 (cg-RX-API-DMAC10.html) 2025-11-12

Family

ID=86242060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525414A Pending JP2024541994A (ja) 2021-11-05 2022-11-04 Akt3モジュレーター

Country Status (10)

Country Link
US (1) US20260159484A1 (cg-RX-API-DMAC10.html)
EP (1) EP4426288A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024541994A (cg-RX-API-DMAC10.html)
KR (1) KR20240116619A (cg-RX-API-DMAC10.html)
CN (1) CN118510502A (cg-RX-API-DMAC10.html)
AU (1) AU2022381763A1 (cg-RX-API-DMAC10.html)
CA (1) CA3236912A1 (cg-RX-API-DMAC10.html)
IL (1) IL312440A (cg-RX-API-DMAC10.html)
MX (1) MX2024005276A (cg-RX-API-DMAC10.html)
WO (1) WO2023081841A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021212111A1 (en) * 2020-04-17 2021-10-21 Augusta University Research Institute, Inc. Compositions and methods for treating leukemia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007004403A (es) * 2004-10-12 2007-04-27 Astrazeneca Ab Derivados de quinazolina.
EP1867638A1 (de) * 2006-06-16 2007-12-19 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Verfahren zur kovalenten Verknüpfung zweier Moleküle mittels Diels-Alder-Reaktion mit inversem Elektronenbedarf
US20100144733A1 (en) * 2008-04-28 2010-06-10 Institute For Oneworld Health Compounds, compositions and methods comprising heteroaromatic derivatives
EP2316820A1 (en) * 2009-10-28 2011-05-04 Dompe S.p.A. 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
US10292978B2 (en) * 2016-01-15 2019-05-21 Augusta University Research Institute, Inc. Specific Akt3 inhibitor and uses thereof
US10342868B2 (en) * 2016-01-15 2019-07-09 Augusta University Research Institute, Inc. Methods and compositions for inhibiting Akt3
US11291719B2 (en) * 2016-01-15 2022-04-05 Augusta University Research Institute, Inc. Methods and compositions for modulating Akt3
EP3609882B1 (en) * 2017-03-17 2022-07-13 Cardio Therapeutics Pty Ltd Heterocyclic inhibitors of pcsk9
US11129909B2 (en) * 2017-05-08 2021-09-28 University Of Science And Technology Of China Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof
EP3678666B1 (en) * 2017-09-07 2025-07-09 Augusta University Research Institute, Inc. Specific akt3 activator and uses thereof
WO2020168241A1 (en) * 2019-02-15 2020-08-20 Flagship Pioneering Inc. X-reactivation modulators and uses thereof

Similar Documents

Publication Publication Date Title
AU2019231725B2 (en) 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP2024540107A5 (cg-RX-API-DMAC10.html)
JP2024541995A5 (cg-RX-API-DMAC10.html)
JP6043338B2 (ja) 抗ウイルス治療用の1’−置換ピリミジンn−ヌクレオシド類似体
JP2019501133A5 (cg-RX-API-DMAC10.html)
JP6554117B2 (ja) 医療で使用されるインドール誘導体
JP2013535460A5 (cg-RX-API-DMAC10.html)
JP2016529324A5 (cg-RX-API-DMAC10.html)
US8815918B2 (en) Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives
JP2017160233A5 (cg-RX-API-DMAC10.html)
JP2019527718A5 (cg-RX-API-DMAC10.html)
BR0316407A (pt) Derivados de nucleosìdeo antiviral
JP2023525757A5 (cg-RX-API-DMAC10.html)
JP2010065035A5 (cg-RX-API-DMAC10.html)
JP2018519343A5 (cg-RX-API-DMAC10.html)
CY1115836T1 (el) Παραγωγα πυραζινονης και η χρηση τους στη θεραπευτικη αντιμετωπιση παθησεων των πνευμονων
JP2012507566A5 (cg-RX-API-DMAC10.html)
RU2011108024A (ru) 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов
CA2643177A1 (en) Multi-cyclic compounds for treating cancer
JP2015524472A5 (cg-RX-API-DMAC10.html)
JP2014512364A5 (cg-RX-API-DMAC10.html)
JP2012506872A5 (cg-RX-API-DMAC10.html)
JP2018519834A5 (cg-RX-API-DMAC10.html)
JP2023164918A5 (cg-RX-API-DMAC10.html)